Chandigarh, November 27
While the Central Drugs Standard Control Organisation (CDSCO) has claimed that an FIR could not be lodged against the drug manufacturing firm with the PGIMER, Chandigarh, failing to provide a detailed report on the death of six persons following the administration of Propofol injection, the hospital authorities say that the inquiry report was submitted to the Drug Control Authority, Chandigarh, for further course of action.
The blame game continues even as the victim’s identity remains in dark. No compensation has been promised to the families of those who died due to adverse events after being given the anaesthetic drug. The UT Administration had maintained that there is no further role of the Drug Control Authority, Chandigarh, and the matter was already brought into the notice of the Drug Controller General of India.
The UT Drug Controller, Dr Suman Singh, said it was the PGI authorities who had to send the report to the CDSCO and “we are in no position to share their internal report with any other authority”.
A PGI source privy to the development said, “We had submitted the report to the Drug Control Authority in which we held the manufacturer accountable for the adverse events. FIR cannot be lodged from the institute’s end as it is for the drug authorities to initiate proceedings under the Drugs and Cosmetics Act. The investigation is going on at the central level.”
